AbbVie Inc/ US00287Y1091 /
| 2024-04-19 10:10:00 PM | Chg. +1.75 | Volume | Bid1:00:33 AM | Ask1:00:33 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 166.41USD | +1.06% | 5.53 mill. Turnover: 622.28 mill. |
166.20Bid Size: 100 | 166.35Ask Size: 100 | 293.96 bill.USD | 3.60% | 60.96 |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 2.73 USD | -58.95% |
| EPS Diluted: | 2.72 USD | -58.97% |
| Revenues per Share: | 30.75 USD | -6.28% |
| Book Value per Share: | 5.89 USD | -39.76% |
| Cash Flow per Share: | 12.93 USD | -8.28% |
| Dividend per Share: | 5.99 USD | 4.90% |
| Total | in mill. | |
| Revenues: | 54,318.00 USD | -6.44% |
| Net Income: | 4,863.00 USD | -58.91% |
| Operating Cash Flow: | 22,839.00 USD | - |
| Cash and Cash Equivalents: | 12,814.00 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 60.96 | 56.77 |
| P/S Ratio: | 5.41 | 5.04 |
| P/BV ratio: | 28.27 | 26.33 |
| P/CF Ratio: | 12.87 | 11.99 |
| PEG: | -1.03 | -0.96 |
| Earnings Yield: | 1.64% | 1.76% |
| Dividend Yield: | 3.60% | 3.87% |
| Market Capitalization | ||
| Market Capitalization: | 293.96 bill. USD | 273.75 bill. USD |
| Free Float Market Cap.: | - USD | - USD |
| Market Cap. / Employee: | - USD | - USD |
| Shares Outstanding: | 1.77 bill. | |
Profitability
| Gross Profit Margin: | 62.42% |
| EBIT Margin: | 23.49% |
| Net Profit Margin: | 8.95% |
| Return on Equity: | 46.77% |
| Return on Assets: | 3.61% |
Financial Strength
| Liquidity I / Cash Ratio: | 33.86% |
| Liquidity II / Quick Ratio: | 63.34% |
| Liquidity III / Current Ratio: | 87.21% |
| Debt / Equity Ratio: | 1,195.67% |
| Dynam. Debt / Equity Ratio: | 544.31% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | - USD |
| Net Income / Employee: | - USD |
| Total Assets / Employee: | - USD |
| * Fiscal Year End: | 2023-12-31 |
| Accounting Standard: | US GAAP |
| Currency: | USD |
